Status:
COMPLETED
Percutaneous Release vs Steroid Injection for Trigger Finger
Lead Sponsor:
Armed Police Force Hospital, Nepal
Conditions:
Trigger Finger
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Trigger fingers (TF) is the common cause of pain and disturbed function of hand. Many studies show that percutaneous release of A1 pulley has better outcome than the steroid injection. However, over t...
Detailed Description
Stenosing flexor tenosynovitis also known as trigger finger. It is a common clinical condition where there is locking and clicking during flexion and extension of the involved digit or even locking. T...
Eligibility Criteria
Inclusion
- Participants aged 18 years and above
- Duration of symptoms :≥ 3 months
- Triggering in any of the digits of hand
- Trigger finger type II-IV based on Quinnell classification
Exclusion
- There is prior treatment for trigger finger, or Trigger thumb
- There had been previous surgery or other hand pathology such as rheumatoid arthritis, osteoarthritis, Dupuytren's contracture and diabetic mellitus.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 2 2022
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT05383040
Start Date
June 1 2022
End Date
November 2 2022
Last Update
February 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Armed Police Force Hospital
Kathmandu, Bagmati, Nepal, +9779851147339